Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2024-04-09 | Athena Countouriotis, M.D. joined our Board in December 2023. Dr. Countouriotis is co-founder, President, Chief Executive Officer and Chairperson of Avenzo Therapeutics, Inc., a private biotechnology company, since October 2022. ... 2023 Independent Director Compensation ... Athena Countouriotis, M.D. — Fees Earned or Paid in Cash, 213,378 Stock Awards, 213,378 Total. |
| 2025-04-08 | Athena Countouriotis, M.D. joined our Board in December 2023. Dr. Countouriotis is co-founder, President, Chief Executive Officer and Chairperson of Avenzo Therapeutics, Inc. She holds a B.S. in Physiology from UCLA and an M.D. from Tufts University School of Medicine. 2024 Non-Employee Director Compensation: Athena Countouriotis, M.D. received total compensation of $445,045. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-27 | "Dr. Countouriotis holds an undergraduate degree from the University of California, Los Angeles and an M.D. from the Tufts University School of Medicine... because of her medical and business background and education..." |
| 2021-04-27 | "Dr. Countouriotis holds an undergraduate degree from the University of California, Los Angeles and an M.D. from the Tufts University School of Medicine." |
| 2022-04-27 | "Dr. Countouriotis is the President and Chief Executive Officer of Turning Point Therapeutics... Dr. Countouriotis holds an undergraduate degree... and an M.D. from the Tufts University School of Medicine." |
| 2023-04-26 | "Dr. Countouriotis is the co-founder and Chief Executive Officer of Avenzo Therapeutics... She received training... in the Pediatric Hematology-Oncology Program." |
| 2024-04-29 | "Dr. Countouriotis is the co-founder and Chief Executive Officer of Avenzo Therapeutics... Dr. Countouriotis holds an undergraduate degree... and an M.D. from the Tufts University School of Medicine." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-06-10